TY - JOUR
T1 - Cost of transferring one through five embryos per in vitro fertilization cycle from various payor perspectives
AU - Little, Sarah E.
AU - Ratcliffe, Jennifer
AU - Caughey, Aaron B.
PY - 2006/9
Y1 - 2006/9
N2 - We sought to examine the costs of transferring one through five embryos per in vitro fertilization cycle from each of three perspectives: society, the infertile couple, and the insurer. Data from the 2003 Assisted Reproductive Technology Report was used to create Markov decision analytic models stratified by maternal age subgroup. We modeled both total costs, cost-effectiveness (cost per live birth), and clinical outcomes: multiple births, preterm deliveries, and cerebral palsy. From a societal and insurer perspective, it was least expensive to transfer one embryo. For women aged younger than 35 years, it cost society 80% more to transfer five rather than one embryo at a time (total cost $39,212 compared with $21,661). For women aged older than 42 years, it cost 13% more ($29,102 compared with $25,723). From a parental perspective, it was least expensive to transfer between two and five embryos, depending on maternal age. One-embryo transfers markedly improved clinical outcomes. For example, two compared with one-embryo transfers for women aged younger than 35 years reduced preterm birth and cerebral palsy rates by 55% and 41%, respectively. Univariable sensitivity analysis and Monte Carlo simulation showed our results to be robust. Transferring one embryo per cycle is the least expensive strategy from a societal perspective, especially for younger women, yet it is the most expensive option from a parental perspective. To reduce in vitro fertilization-associated multiple birth rates, public policy must address these disparate financial incentives.
AB - We sought to examine the costs of transferring one through five embryos per in vitro fertilization cycle from each of three perspectives: society, the infertile couple, and the insurer. Data from the 2003 Assisted Reproductive Technology Report was used to create Markov decision analytic models stratified by maternal age subgroup. We modeled both total costs, cost-effectiveness (cost per live birth), and clinical outcomes: multiple births, preterm deliveries, and cerebral palsy. From a societal and insurer perspective, it was least expensive to transfer one embryo. For women aged younger than 35 years, it cost society 80% more to transfer five rather than one embryo at a time (total cost $39,212 compared with $21,661). For women aged older than 42 years, it cost 13% more ($29,102 compared with $25,723). From a parental perspective, it was least expensive to transfer between two and five embryos, depending on maternal age. One-embryo transfers markedly improved clinical outcomes. For example, two compared with one-embryo transfers for women aged younger than 35 years reduced preterm birth and cerebral palsy rates by 55% and 41%, respectively. Univariable sensitivity analysis and Monte Carlo simulation showed our results to be robust. Transferring one embryo per cycle is the least expensive strategy from a societal perspective, especially for younger women, yet it is the most expensive option from a parental perspective. To reduce in vitro fertilization-associated multiple birth rates, public policy must address these disparate financial incentives.
UR - http://www.scopus.com/inward/record.url?scp=33748339204&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33748339204&partnerID=8YFLogxK
U2 - 10.1097/01.AOG.0000230534.54078.b3
DO - 10.1097/01.AOG.0000230534.54078.b3
M3 - Article
C2 - 16946220
AN - SCOPUS:33748339204
SN - 0029-7844
VL - 108
SP - 593
EP - 601
JO - Obstetrics and Gynecology
JF - Obstetrics and Gynecology
IS - 3
ER -